Drug Approval | September 15, 2023
Strides receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company's facility in Bengaluru
The products will be manufactured at the company's facility in Bengaluru
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The product is expected to start contributing meaningfully to the revenue from FY25
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The brand has launched 6 new range of products to provide a complete pregnancy care solution
The products will be manufactured at the company's facility in Bengaluru
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Subscribe To Our Newsletter & Stay Updated
